Enhancing global hepatocellular carcinoma management: Bridging Eastern and Western perspectives on dexamethasone and N-acetylcysteine before transarterial chemoembolization

Table 1 Corticosteroid comparison chart

	Equivalent glucocorticoid dose (mg)	Potency relative to hydrocortisone		Half-life
		Anti-inflammatory	Mineralo-corticoid	Plasma (minutes)	Duration of action (hours)
Glucocorticoids
Short acting
Hydrocortisone	20	1	1	90	8–12
Cortisone acetate	25	0.8	0.8	30	8–12
Intermediate acting
Prednisone	5	4	0.8	60	12–36
Prednisolone	5	4	0.8	200	12–36
Triamcinolone	4	5	0	300	12–36
Methyl-prednisolone	4	5	0.5	180	12–36
Long acting
Dexamethasone	0.75	30	0	200	36–54
Betamethasone	0.6	30	0	300	36–54
Mineralo-corticoids
Fludrocortisone	0	15	150	240	24–36
Aldosterone	0	0	> 400	20	-